Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Receives Export License for Anthrax Testing System

NEW YORK, April 15 (GenomeWeb News) - Cepheid has received a license from the US State Department to export its anthrax testing system to governments in Europe, the company said today.


The export license allows Sunnyvale, Calif.-based Cepheid to market its GeneXpert system and anthrax test cartridge to government agencies in the UK, Germany, France, Belgium, and Switzerland.


According to Cepheid, its system allows users to detect the anthrax bacterium in samples within 30 minutes.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.